Notable Analyst Upgrades and Downgrades (NASDAQ: SSYS) (TSX: DR)

Published:

The following stocks were upgraded/downgraded on March 21, 2014
Company Name Exchange Ticker Last Price Total Analyst Coverage Upgrade/
Downgrade
Analyst Name Rating Company Target Price Upside/
Downside (%)
Medical Facilities Corp TSX DR 19.51 5 Upgrade to buy from hold Lennox Gibbs TD Securities 21.00 7.6%
CWC Well Services Corp TSXV CWC 0.89 3 Downgrade to sector perform from outperform Jason Sawatzky Alta Corp Capital Inc. 1.05 18.0%
Newalta Corp TSX NAL 19.37 10 Downgrade to sector perform from sector outperform David Noseworthy CIBC World Markets 20.00 3.3%
InnVest Real Estate Investment Trust TSX INN-U 5.18 6 Downgrade to sector perform from outperform Neil Downey RBC Capital Markets 5.50 6.2%

TD Securities upgraded Medical Facilities Corp (TSX: DR), which owns a majority interest in each of four specialty surgical hospitals (SSHs) as well as a majority interest in one ambulatory surgery center (ASC), to buy from hold increasing its price target to C$21.00 from C$15.00, indicating an upside of 7.6% from current levels. DR recently reported that its fourth quarter 2013 revenues grew 24.7% to C$89.6 million over the same period last year, while revenues for full year 2013 were up 29.2% over the last year. Income from operations for the quarter and full year were up 28.1% & 15.7% respectively over the corresponding period last year.

Alta Corp Capital Inc. downgraded CWC Well Services Corp (TSXV: CWC), a Canada-based oilfield services company providing production services to oil and gas exploration and development companies, to sector perform from outperform with a price target of C$1.05, indicating an upside of 18% from current levels.

Newalta Corp (TSX: NAL), engaged in recycling and recovering saleable products from industrial wastes through a network of facilities, was downgraded to sector perform from sector outperform at CIBC World Markets with a price target of C$20.00, indicating an upside of 3.3% from current levels.

RBC Capital Markets downgraded InnVest Real Estate Investment Trust (TSX: INN-U), an unincorporated open-ended real estate investment trust (REIT), to sector perform from outperform with a price target of C$5.50, indicating an upside of 6.2% from current levels.

The following stocks were upgraded/downgraded on March 21, 2014
Company Name Exchange Ticker Last Price Total Analyst
Coverage
Upgrade/
Downgrade
Analyst Name Rating Company Target Price Upside/
Downside (%)
Stratasys Ltd NASDAQ SSYS 106.45 22 Upgrade to overweight from neutral Paul T Coster JPMorgan 125.00 17.4%
JDS Uniphase Corp NASDAQ JDSU 14.62 17 Upgrade to buy from neutral Michael Genovese MKM Partners 18.00 23.2%
Schnitzer Steel Industries Inc NASDAQ SCHN 28.78 10 Initiate with buy Thomas Van Buskirk Sidoti & Company LLC 35.00 21.6%
Spectranetics Corp NASDAQ SPNC 29.80 10 Initiate with buy Michael S Matson Needham & Co 35.00 17.4%
Exelis Inc NYSE XLS 19.70 8 Downgrade to hold from buy Howard A Rubel Jefferies 20.00 1.5%

JPMorgan upgraded Stratasys Ltd (NASDAQ: SSYS), engaged in manufacturing three-dimensional printers, to overweight from neutral with a price target of $125.00, indicating an upside of 17.4% from current levels.

JDS Uniphase Corp (NASDAQ: JDSU), a provider of communications test and measurement solutions and optical products, was upgraded to buy from neutral at MKM Partners raising its price target to $18.00 from $15.00, indicating an upside of 23.2% from current levels. The rating firm believes that increase in the global carrier capex environment and positive product-mix trends will yield higher margins for the company. Analyst Michael Genovese notes that company’s TDD-LTE drive test and base station analyzers in addition to 100G optical components appears positive for capex growth at China Mobile.

Sidoti & Company LLC initiated coverage Schnitzer Steel Industries Inc (NAASDAQ: SCHN), a recycler of ferrous and nonferrous scrap metal, with a buy rating assigning a 12-month price target of $35.00, indicating an upside of 21.6% from current levels. The company is scheduled to report its second quarter earnings for fiscal 2014 on April 3, 2014.

Coverage on Spectranetics Corp (NASDAQ: SPNC), engaged in developing, manufacturing, marketing and distributing single-use medical devices used in minimally invasive procedures within the cardiovascular system, was initiated with buy at Needham & Co with a 12-month price target of $35.00, indicating an upside of 17.4% from current levels.

Jefferies downgraded Exelis Inc (NYSE: XLS), engaged in Command, Control, Communications, Computers, Intelligence, Surveillance and Reconnaissance (C4ISR) related products and systems and information and technical services, to hold from buy with a price target of $20.00, indicating an upside of 1.5% from current levels.

Related articles

Recent articles